Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer

Our previously reported randomized study of patients with untreated, potentially resectable clinical stage IIIA non-small-cell lung cancer found that patients treated with perioperative chemotherapy and surgery had a significant increase in median survival compared to patients treated with surgery a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lung cancer (Amsterdam, Netherlands) Netherlands), 1998-07, Vol.21 (1), p.1-6
Hauptverfasser: Roth, Jack A, Atkinson, E.Neely, Fossella, Frank, Komaki, Ritsuko, Ryan, M.Bernadette, Putnam, J.B, Lee, Jin Soo, Dhingra, Hari, De Caro, Louis, Chasen, Marvin, Hong, Waun Ki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6
container_issue 1
container_start_page 1
container_title Lung cancer (Amsterdam, Netherlands)
container_volume 21
creator Roth, Jack A
Atkinson, E.Neely
Fossella, Frank
Komaki, Ritsuko
Ryan, M.Bernadette
Putnam, J.B
Lee, Jin Soo
Dhingra, Hari
De Caro, Louis
Chasen, Marvin
Hong, Waun Ki
description Our previously reported randomized study of patients with untreated, potentially resectable clinical stage IIIA non-small-cell lung cancer found that patients treated with perioperative chemotherapy and surgery had a significant increase in median survival compared to patients treated with surgery alone. We have now re-analyzed the results of the study with a median time from random allocation to analysis for all patients of 82 months. The increase in survival conferred by perioperative chemotherapy was maintained during the period of extended observation.
doi_str_mv 10.1016/S0169-5002(98)00046-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70002812</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0169500298000464</els_id><sourcerecordid>70002812</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-10b8df202bcfbcf61cf0659dbd40bee3ce61ec306f769fe7925a2f88b2294acf3</originalsourceid><addsrcrecordid>eNqFUU2LFDEQDaKs4-pPWMhBRA_RJN3TnZxkWfwYGPCgnkM6XZmJpJM2Se8y_jB_n5mdYa5CqFBV71UV7yF0w-h7Rln34XsNkqwp5W-leEcpbTvSPkErJnpORNPwp2h1gTxHL3L-RSnrGZVX6Er2ktNWrNDfbQw7UiBN2Ebv4wNZZhwtnnVxEErGEFKtw4hdwBonHcY4uT81L8lpj02cZp1c2OEZkos1VOI9YLOHKZZ9TecDriScl7SDdMAPruwvifYxwHFyggym6MEDzkXvAG82m1scYiB50t4TA95jv9Q1RgcD6SV6ZrXP8Or8X6Ofnz_9uPtKtt--bO5ut8Q0QhbC6CBGyykfjK2vY8bSbi3HYWzpANAY6BiYhna276SFKspacyvEwLlstbHNNXpzmjun-HuBXNTk8vEYHSAuWfVVdy4Yr8D1CWhSzDmBVXNyk04Hxag6-qUe_VJHM5QU6tEv1VbezXnBMkwwXlhng2r_9bmvs9HeVgOMyxcYbxntW1ZhH08wqGLcO0gqm-qfgdGlKqwao_vPIf8AhK63CA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70002812</pqid></control><display><type>article</type><title>Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Roth, Jack A ; Atkinson, E.Neely ; Fossella, Frank ; Komaki, Ritsuko ; Ryan, M.Bernadette ; Putnam, J.B ; Lee, Jin Soo ; Dhingra, Hari ; De Caro, Louis ; Chasen, Marvin ; Hong, Waun Ki</creator><creatorcontrib>Roth, Jack A ; Atkinson, E.Neely ; Fossella, Frank ; Komaki, Ritsuko ; Ryan, M.Bernadette ; Putnam, J.B ; Lee, Jin Soo ; Dhingra, Hari ; De Caro, Louis ; Chasen, Marvin ; Hong, Waun Ki</creatorcontrib><description>Our previously reported randomized study of patients with untreated, potentially resectable clinical stage IIIA non-small-cell lung cancer found that patients treated with perioperative chemotherapy and surgery had a significant increase in median survival compared to patients treated with surgery alone. We have now re-analyzed the results of the study with a median time from random allocation to analysis for all patients of 82 months. The increase in survival conferred by perioperative chemotherapy was maintained during the period of extended observation.</description><identifier>ISSN: 0169-5002</identifier><identifier>EISSN: 1872-8332</identifier><identifier>DOI: 10.1016/S0169-5002(98)00046-4</identifier><identifier>PMID: 9792048</identifier><identifier>CODEN: LUCAE5</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Antineoplastic Agents - therapeutic use ; Biological and medical sciences ; Carcinoma, Non-Small-Cell Lung - drug therapy ; Carcinoma, Non-Small-Cell Lung - surgery ; Chemotherapy, Adjuvant ; Cisplatin ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Induction chemotherapy ; Lung cancer ; Lung Neoplasms - drug therapy ; Lung Neoplasms - surgery ; Male ; Medical sciences ; Middle Aged ; Randomized trial ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the respiratory system ; Survival Analysis ; Treatment Outcome</subject><ispartof>Lung cancer (Amsterdam, Netherlands), 1998-07, Vol.21 (1), p.1-6</ispartof><rights>1998 Elsevier Science Ireland Ltd</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-10b8df202bcfbcf61cf0659dbd40bee3ce61ec306f769fe7925a2f88b2294acf3</citedby><cites>FETCH-LOGICAL-c389t-10b8df202bcfbcf61cf0659dbd40bee3ce61ec306f769fe7925a2f88b2294acf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0169500298000464$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2410741$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9792048$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roth, Jack A</creatorcontrib><creatorcontrib>Atkinson, E.Neely</creatorcontrib><creatorcontrib>Fossella, Frank</creatorcontrib><creatorcontrib>Komaki, Ritsuko</creatorcontrib><creatorcontrib>Ryan, M.Bernadette</creatorcontrib><creatorcontrib>Putnam, J.B</creatorcontrib><creatorcontrib>Lee, Jin Soo</creatorcontrib><creatorcontrib>Dhingra, Hari</creatorcontrib><creatorcontrib>De Caro, Louis</creatorcontrib><creatorcontrib>Chasen, Marvin</creatorcontrib><creatorcontrib>Hong, Waun Ki</creatorcontrib><title>Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer</title><title>Lung cancer (Amsterdam, Netherlands)</title><addtitle>Lung Cancer</addtitle><description>Our previously reported randomized study of patients with untreated, potentially resectable clinical stage IIIA non-small-cell lung cancer found that patients treated with perioperative chemotherapy and surgery had a significant increase in median survival compared to patients treated with surgery alone. We have now re-analyzed the results of the study with a median time from random allocation to analysis for all patients of 82 months. The increase in survival conferred by perioperative chemotherapy was maintained during the period of extended observation.</description><subject>Antineoplastic Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Non-Small-Cell Lung - drug therapy</subject><subject>Carcinoma, Non-Small-Cell Lung - surgery</subject><subject>Chemotherapy, Adjuvant</subject><subject>Cisplatin</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Induction chemotherapy</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Lung Neoplasms - surgery</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Randomized trial</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the respiratory system</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><issn>0169-5002</issn><issn>1872-8332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUU2LFDEQDaKs4-pPWMhBRA_RJN3TnZxkWfwYGPCgnkM6XZmJpJM2Se8y_jB_n5mdYa5CqFBV71UV7yF0w-h7Rln34XsNkqwp5W-leEcpbTvSPkErJnpORNPwp2h1gTxHL3L-RSnrGZVX6Er2ktNWrNDfbQw7UiBN2Ebv4wNZZhwtnnVxEErGEFKtw4hdwBonHcY4uT81L8lpj02cZp1c2OEZkos1VOI9YLOHKZZ9TecDriScl7SDdMAPruwvifYxwHFyggym6MEDzkXvAG82m1scYiB50t4TA95jv9Q1RgcD6SV6ZrXP8Or8X6Ofnz_9uPtKtt--bO5ut8Q0QhbC6CBGyykfjK2vY8bSbi3HYWzpANAY6BiYhna276SFKspacyvEwLlstbHNNXpzmjun-HuBXNTk8vEYHSAuWfVVdy4Yr8D1CWhSzDmBVXNyk04Hxag6-qUe_VJHM5QU6tEv1VbezXnBMkwwXlhng2r_9bmvs9HeVgOMyxcYbxntW1ZhH08wqGLcO0gqm-qfgdGlKqwao_vPIf8AhK63CA</recordid><startdate>19980701</startdate><enddate>19980701</enddate><creator>Roth, Jack A</creator><creator>Atkinson, E.Neely</creator><creator>Fossella, Frank</creator><creator>Komaki, Ritsuko</creator><creator>Ryan, M.Bernadette</creator><creator>Putnam, J.B</creator><creator>Lee, Jin Soo</creator><creator>Dhingra, Hari</creator><creator>De Caro, Louis</creator><creator>Chasen, Marvin</creator><creator>Hong, Waun Ki</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980701</creationdate><title>Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer</title><author>Roth, Jack A ; Atkinson, E.Neely ; Fossella, Frank ; Komaki, Ritsuko ; Ryan, M.Bernadette ; Putnam, J.B ; Lee, Jin Soo ; Dhingra, Hari ; De Caro, Louis ; Chasen, Marvin ; Hong, Waun Ki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-10b8df202bcfbcf61cf0659dbd40bee3ce61ec306f769fe7925a2f88b2294acf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Antineoplastic Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Non-Small-Cell Lung - drug therapy</topic><topic>Carcinoma, Non-Small-Cell Lung - surgery</topic><topic>Chemotherapy, Adjuvant</topic><topic>Cisplatin</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Induction chemotherapy</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Lung Neoplasms - surgery</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Randomized trial</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the respiratory system</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roth, Jack A</creatorcontrib><creatorcontrib>Atkinson, E.Neely</creatorcontrib><creatorcontrib>Fossella, Frank</creatorcontrib><creatorcontrib>Komaki, Ritsuko</creatorcontrib><creatorcontrib>Ryan, M.Bernadette</creatorcontrib><creatorcontrib>Putnam, J.B</creatorcontrib><creatorcontrib>Lee, Jin Soo</creatorcontrib><creatorcontrib>Dhingra, Hari</creatorcontrib><creatorcontrib>De Caro, Louis</creatorcontrib><creatorcontrib>Chasen, Marvin</creatorcontrib><creatorcontrib>Hong, Waun Ki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Lung cancer (Amsterdam, Netherlands)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roth, Jack A</au><au>Atkinson, E.Neely</au><au>Fossella, Frank</au><au>Komaki, Ritsuko</au><au>Ryan, M.Bernadette</au><au>Putnam, J.B</au><au>Lee, Jin Soo</au><au>Dhingra, Hari</au><au>De Caro, Louis</au><au>Chasen, Marvin</au><au>Hong, Waun Ki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer</atitle><jtitle>Lung cancer (Amsterdam, Netherlands)</jtitle><addtitle>Lung Cancer</addtitle><date>1998-07-01</date><risdate>1998</risdate><volume>21</volume><issue>1</issue><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>0169-5002</issn><eissn>1872-8332</eissn><coden>LUCAE5</coden><abstract>Our previously reported randomized study of patients with untreated, potentially resectable clinical stage IIIA non-small-cell lung cancer found that patients treated with perioperative chemotherapy and surgery had a significant increase in median survival compared to patients treated with surgery alone. We have now re-analyzed the results of the study with a median time from random allocation to analysis for all patients of 82 months. The increase in survival conferred by perioperative chemotherapy was maintained during the period of extended observation.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>9792048</pmid><doi>10.1016/S0169-5002(98)00046-4</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0169-5002
ispartof Lung cancer (Amsterdam, Netherlands), 1998-07, Vol.21 (1), p.1-6
issn 0169-5002
1872-8332
language eng
recordid cdi_proquest_miscellaneous_70002812
source MEDLINE; Elsevier ScienceDirect Journals
subjects Antineoplastic Agents - therapeutic use
Biological and medical sciences
Carcinoma, Non-Small-Cell Lung - drug therapy
Carcinoma, Non-Small-Cell Lung - surgery
Chemotherapy, Adjuvant
Cisplatin
Disease-Free Survival
Female
Follow-Up Studies
Humans
Induction chemotherapy
Lung cancer
Lung Neoplasms - drug therapy
Lung Neoplasms - surgery
Male
Medical sciences
Middle Aged
Randomized trial
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the respiratory system
Survival Analysis
Treatment Outcome
title Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A45%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20follow-up%20of%20patients%20enrolled%20in%20a%20randomized%20trial%20comparing%20perioperative%20chemotherapy%20and%20surgery%20with%20surgery%20alone%20in%20resectable%20stage%20IIIA%20non-small-cell%20lung%20cancer&rft.jtitle=Lung%20cancer%20(Amsterdam,%20Netherlands)&rft.au=Roth,%20Jack%20A&rft.date=1998-07-01&rft.volume=21&rft.issue=1&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=0169-5002&rft.eissn=1872-8332&rft.coden=LUCAE5&rft_id=info:doi/10.1016/S0169-5002(98)00046-4&rft_dat=%3Cproquest_cross%3E70002812%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70002812&rft_id=info:pmid/9792048&rft_els_id=S0169500298000464&rfr_iscdi=true